Pancreatic Diffuse Large B-cell Lymphoma in the

被引:3
作者
Ullah, Asad [1 ]
Lee, Kue T. [2 ]
Malham, Kali [3 ]
Yasinzai, Abdul Qahar Khan [4 ]
Tareen, Bisma [5 ]
Lopes, Dara [6 ]
Wali, Agha [5 ]
Zarate, Luis Velasquez [7 ]
Waheed, Abdul [6 ]
Wiest, Maya [6 ]
Hakim, Resham [8 ]
Khan, Marjan [9 ]
Asif, Bina [10 ]
Patel, Nikhil [7 ]
Hakim, Sahar [11 ]
Kakar, Kaleemullah [5 ]
Heneidi, Saleh [12 ]
Karki, Nabin R. [13 ]
Sidhwa, Feroze [14 ]
机构
[1] Vanderbilt Univ, Pathol, Med Ctr, Nashville, TN 37232 USA
[2] Augusta Univ, Med Coll Georgia, Otolaryngol, Augusta, GA USA
[3] Augusta Univ, Med Coll Georgia, Gastroenterol, Augusta, GA USA
[4] Bolan Med Coll, Surg, Quetta, Pakistan
[5] Bolan Med Coll, Internal Med, Quetta, Pakistan
[6] San Joaquin Gen Hosp, French Camp, CA USA
[7] Augusta Univ, Med Coll Georgia, Pathol, Augusta, GA USA
[8] San Joaquin Gen Hosp, Internal Med, French Camp, CA USA
[9] Marshfield Clin Fdn Med Res & Educ, Internal Med, Marshfield, WI USA
[10] Bannu Med Coll, Med, Bannu, Pakistan
[11] San Joaquin Gen Hosp, Cardiol, French Camp, CA USA
[12] Cedars Sinai Med Ctr, Pathol, Los Angeles, CA USA
[13] Univ S Alabama, Mitchell Canc Inst, Oncol, Mobile, AL USA
[14] San Joaquin Gen Hosp, Gen Surg Trauma & Crit Care, French Camp, CA USA
关键词
multivariable analysis; chemotherapy; seer; diffuse large b -cell lymphoma; pancreatic lymphomas; DIAGNOSIS; RITUXIMAB;
D O I
10.7759/cureus.39862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Results: The most common age group was between the ages of 70 and 79 years (27.0%). While 44% of cases involved distant sites (a proxy for secondary pancreatic DLBCL), regional and localized involvement was seen in 33%, with the most common cause of death being a primary pancreatic DLBCL. Most patients (71%) received only chemotherapy (systemic therapy). The overall five-year observed survival was 46% (95% CI, 43.5-48.3). The one-year and five-year survival with chemotherapy only was 68% (95% CI, 65.3-70.3) and 48% (95% CI, 44.7-50.5), respectively. The one-year and five-year survival with surgery and chemotherapy was 96% (95% CI, 91.3-99.9) and 80% (95% CI, 71.4-89.2), respectively. Surgery with chemotherapy (HR: 0.397 (95% CI, 0.197-0.803), p = 0.010) were both positive predictors in survival prognosis. Multivariable analysis identified age >55 years (HR: 2.475 (95% CI, 1.770-3.461), p < 0.001), distant stage (HR: 6.894 (95% CI, 4.121-11.535), p < 0.001), and undergoing no surgery (HR: 2.610 (95% CI, 1.307-5.215), p = 0.007) as negative predictors for survival.
引用
收藏
页数:11
相关论文
共 21 条
[1]   Primary Pancreatic Lymphoma Masquerading as Carcinoma [J].
Alzerwi, Nasser A. N. .
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
[2]   Non-Hodgkin lymphoma [J].
Armitage, James O. ;
Gascoyne, Randy D. ;
Lunning, Matthew A. ;
Cavalli, Franco .
LANCET, 2017, 390 (10091) :298-310
[3]   Primary pancreatic lymphoma - Diagnostic and therapeutic dilemma [J].
Battula, Narendra ;
Srinivasan, Parthi ;
Prachalias, Andreas ;
Rela, Mohamed ;
Heaton, Nigel .
PANCREAS, 2006, 33 (02) :192-194
[4]   PANCREATIC LYMPHOMA - IS IT A SURGICAL DISEASE [J].
BEHRNS, KE ;
SARR, MG ;
STRICKLER, JG .
PANCREAS, 1994, 9 (05) :662-667
[5]   Primary Pancreatic lymphoma: a rare clinical entity [J].
Dunphy, Louise ;
Abbas, Syed Hussain ;
Al Shoek, Ihsan ;
Al-Salti, Wassim .
BMJ CASE REPORTS, 2020, 13 (01)
[6]  
Facchinelli D, 2021, J BLOOD MED, V12, P257, DOI [10.2147/JBM.S273095, 10.2147/IJBM.S273095]
[7]  
FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO
[8]  
2-#
[9]   Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era [J].
Gisselbrecht, Christian ;
Glass, Bertram ;
Mounier, Nicolas ;
Gill, Devinder Singh ;
Linch, David C. ;
Trneny, Marek ;
Bosly, Andre ;
Ketterer, Nicolas ;
Shpilberg, Ofer ;
Hagberg, Hans ;
Ma, David ;
Briere, Josette ;
Moskowitz, Craig H. ;
Schmitz, Norbert .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) :4184-4190
[10]   Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma [J].
Gupta, Varsha ;
Singh, Vinit ;
Bajwa, Ravneet ;
Meghal, Trishala ;
Sen, Shuvendu ;
Greenberg, David ;
Anne, Madhurima ;
Levitt, Michael J. .
JOURNAL OF HEMATOLOGY, 2022, 11 (02) :45-54